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ABSTRACT
Background and Objectives: There are currently limited data available regarding the safety of endoscopic ultrasound (EUS)‑guided
drainage of pancreatic fluid collections (PFCs) using the lumen‑apposing metal stent without fluoroscopic guidance. This study
aims to evaluate clinical outcomes and safety of EUS‑guided drainage of PFC using the electrocautery‑enhanced lumen‑apposing
metal stents (EC‑LAMSs) without fluoroscopic guidance. Methods: We conducted a retrospective study on patients with
symptomatic PFC who underwent EUS‑guided drainage using EC‑LAMS without fluoroscopy. All patients were followed
clinically until resolution of their PFC. Technical success (successful placement of EC‑LAMS), number of patients who achieved
complete resolution of PFC without additional intervention and adverse events were noted. Results: We evaluated 25 patients,
including three with pancreatic pseudocysts and 22 with walled-off necrosis (WON).  The etiology of the patient’s pancreatitis
was gallstones (42%), alcohol (27%), and other causes (31%). The mean cyst size was 82 mm (range, 60–170 mm). The
indications for endoscopic drainage were abdominal pain, infected WON, or gastric outlet obstruction. Technical success with
placement of the EC‑LAMS was achieved in all 25 patients. There were no procedure‑related complications. The mean patient
follow‑up was 7.8 months. PFCs resolved in 24 (96%) patients; the one failure was in a patient with WON. Stent occlusion
was seen in one patient. There was a spontaneous migration of one stent into the enteral lumen after resolution of WONs. The
EC‑LAMS were successfully removed using a snare in all the remaining patients. The median number of endoscopy sessions
to achieve PFCs resolution was 2 (range, 2–6). Conclusions: Single‑step EUS‑guided drainage of PFCs without fluoroscopic
guidance using the novel EC‑LAMS is a safe and effective endoscopic technique for drainage of PFCs with excellent technical
and clinical success rates and no complications. Due to its ease of use, EC‑LAMS may simplify and streamline EUS‑guided
management of PFC and help in its widespread adoption as an alternative to surgery.
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INTRODUCTION
Pancreatic fluid collections (PFCs) develop in the
setting of damage to the major pancreatic duct and/or
peripheral ducts as a complication of acute or chronic
pancreatitis, trauma, iatrogenic causes (i.e., surgery),
or in patients with disconnected duct syndrome.[1‑3]
PFCs include pancreatic pseudocysts (PP) and
walled‑off necrosis (WON).[1] The majority of PFCs
are asymptomatic and will resolve spontaneously. [4]
However, if a PFC persists, therapeutic intervention
is indicated when complications develop, such as
infection, compression of neighboring large vessels, or
obstruction of the duodenum, stomach, or common
bile duct.[5] Intervention is also indicated when PFCs
cause symptoms such as nausea, vomiting, abdominal
pain, or early satiety.[4]
The current therapeutic interventions available for
PFCs include surgical, percutaneous, and endoscopic
drainage.[6,7] Studies have demonstrated that the success
rate of endoscopic intervention is comparable to that
of percutaneous and surgical intervention. Endoscopic
intervention has decreased morbidity, length of hospital
stay, and cost when compared to percutaneous or
surgical intervention. [8,9] The surgical approach is
associated with a high morbidity and mortality, whereas
the percutaneous approach carries the risk of fistula
formation, cyst recurrence, and infections. In the
last decade, endoscopic‑guided drainage of PFCs
through placement of transmural stents has become
the procedure of choice and is considered first‑line
therapy.[10,11] The clinical success of endoscopic‑guided
PFC drainage is related to the type of collection, with a
success rate >90% for PPs, and a slightly lower success
rate of 50%–65% for WON, given the increased
risk of stent occlusion in the presence of necrotic
contents.[9]
Recently, a novel “saddle‑shaped” lumen‑apposing
fully covered self‑expanding metal stent (LAMS) has
been used and shown to be safe and effective for
endoscopic transmural drainage of PFCs with technical
success rates of 89%–100% and clinical success rates
of 88%–100%.[12‑14]
The latest development in therapeutic options is
the LAMS with an electrocautery‑enhanced delivery
system (EC‑LAMS). EC‑LAMS may enable clinicians
to perform endoscopic‑guided drainage of PFCs in
a faster and safer manner by decreasing the number
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of steps needed. In addition, while endoscopic‑guided
drainage of PFCs has typically utilized fluoroscopy to
optimize visualization and access into the PFCs, the
EC‑LAMS system has the potential to be done safely
and effectively without fluoroscopic guidance. While
the use of LAMS under fluoroscopic guidance has
already been shown to be promising,[14] the objective
of this retrospective study was to demonstrate
the safety and clinical outcomes of endoscopic
ultrasound (EUS)‑guided drainage of PFCs using
EC‑LAMS without fluoroscopic guidance.
METHODS
This was a multi‑center retrospective study conducted
at two tertiary care centers and approved by the
Institutional Review Boards at both centers.
Patients who underwent EUS‑guided drainage of PFCs
using the EC‑LAMS without fluoroscopic guidance
were identified from the endoscopy database at Thomas
Jefferson University Hospital and Borland‑Groover
Clinic. WON was identified as a mature, encapsulated
collection of pancreatic and/or peripancreatic necrotic
tissue enclosed in an enhancing wall of reactive tissue.
PPs were defined as encapsulated collections of fluid
within a well‑defined inflammatory wall usually outside
the pancreas with minimal or no necrosis (as per the
Revised Atlanta Classification).[11]
PFCs were characterized by magnetic resonance
imaging or computed tomography in concordance
with
EUS‑findings.
The
indications
for
drainage of PFCs were as follows: (1) refractory
abdominal pain, (2) gastric outlet or biliary
obstruction, (3) ongoing systemic illness, anorexia,
and weight loss, (4) rapidly enlarging PFCs,
and/or (5) infected PFCs.[15] Patients with suspected
cystic neoplasms, coagulopathy (INR >1.5) and
thrombocytopenia (platelets <50,000/mm 3 ), or
imaging showing that the pseudocyst wall was not in
close (>1 cm) to the EUS probe were all excluded from
the study. Data on procedural details and overall clinical
course of the patient were collected from outpatient
and hospital records.

Description of the electrocautery‑enhanced
lumen‑apposing metal stents

The novel device utilized in this study, the EC‑LAMS
and delivery system, is a through‑the‑scope stent with
electrocautery at the distal tip of the delivery system.
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The stent itself has bilateral double‑walled anchoring
flanges designed to hold the stomach or duodenal
wall in direct apposition to PFC wall.[16] The stent is
10 mm in length and available in two different lumen
diameters (10 mm and15 mm).

Techniques

All patients underwent procedures by two endoscopists.
PFC drainage was performed using the therapeutic
linear array echoendoscope (Olympus; Center
Valley, PA, USA). All procedures were performed
under general anesthesia, and patients were given
broad‑spectrum antibiotics during and after
the procedure to decrease the risk of secondary
infection. EUS imaging was employed to determine
the optimal puncture site of the cyst (trans‑gastric or
transduodenal). Color Doppler was used to exclude
interposed vessels at the puncture site. The PFCs were
accessed from the stomach or duodenum directly with
the EC‑LAMS. The electrocautery tip aided passage
of the catheter from the endoscope instrumentation
channel into the PFC through a direct puncture of the
cyst cavity without the need for wire guidance under
fluoroscopy and without the need for additional dilation
of the tract. The distal flange was deployed under
EUS‑guidance followed by positioning of this flange
against the PFC wall. Deployment of the proximal
flange was then performed under endoscopic guidance
without fluoroscopic assistance. The selection of stent
diameter (10 mm or 15 mm) was at the discretion of
the endoscopist. In cases of WONs, a 15‑mm diameter
was preferred because the larger diameter would
allow access to the cavity for future direct endoscopic
necrosectomies and better clearance of necrotic debris.
The deployed stent lumen was then dilated up to
10 mm or 15 mm with a controlled radial expansion
balloon to allow for optimal stent luminal expansion.
In patients with WON, endoscopic necrosectomy
sessions were performed using an upper endoscope
advanced through the EC‑LAMS at scheduling
preference of the endoscopist, usually every 3–7 days
until complete resolution of the necrotic cavity as
confirmed endoscopically and/or by cross‑sectional
imaging.
Immediate complications during or within 1 week
after the procedures, such as perforation, bleeding,
hypotension, or respiratory distress were carefully
documented. The electronic medical records of hospital
admissions and ambulatory office visits were also

assessed for any delayed complications (<30‑day after
the procedure).

Patient follow‑up

Stent removal was undertaken when complete
decompression of the PFC was achieved without any
residual fluid component remaining. Patients were then
followed at regular intervals in an outpatient setting
after stent removal.

Outcomes measures

The primary outcome of this study was to evaluate
the “clinical success” of drainage of PFCs through
EC‑LAMS without fluoroscopic guidance. “Clinical
success” was defined as complete resolution of the PFC
and resolution of the patient’s symptoms without the
need for re‑intervention at 3 months following initial
treatment as demonstrated on cross‑sectional imaging
and ambulatory follow‑up.
Secondary outcomes evaluated include technical success,
adverse events (AEs), procedure re‑intervention, number
of endoscopic procedures required for complete
PFC drainage and PFC recurrence rates after stent
removal. Technical success was designated as successful
endoscopic placement of transmural EC‑LAMS into
the PFC cavity.
Immediate procedure related complications were defined
as complications that occurred within 1 week after the
procedure. Re‑interventions were defined as the need
for repeat PFC drainage as a result of stent occlusion,
cyst cavity infection, or enlarging cyst size leading to
symptoms.
RESULTS

Patient demographics and pancreatic fluid collection
characteristics
We identified 25 patients with PFCs in whom
EUS‑guided transmural drainage using the EC‑LAMS
were performed. All PFCs developed after episodes of
acute pancreatitis. The mean age of the patients was
50 years, and 56% were male (80% white and 20%
African American). The etiology of pancreatitis was
gallstone (42%), alcohol (27%), and other causes (31%).
The PFCs were located in the pancreatic head in
3 patients and the pancreatic body/tail in 22 patients.
The mean size of the PFCs was 82 mm in the long
axis (range of 60–170 mm). Of the 25 patients, three
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had PPs, and 22 had WONs. There was no significant
difference in sex, etiology, or cyst size between patients
with PP and WON.

Endoscopic ultrasound‑guided pseudocyst or walled‑off
necrosis drainage procedure characteristics

Of the patients who underwent endoscopy for
drainage of PFCs, 23 (92%) had transgastric drainage
and 2 (8%) had trans‑duodenal drainage. The
cyst‑gastrostomy/duodenostomy tract was dilated with
a balloon in all 25 patients. Ten patients (two with
PP and eight with WON) had a concomitant ERCP
due to a pancreatic duct leak. Successful insertion of
an EC‑LAMS into the PFC cavity (technical success)
was achieved in all 25 (100%) patients. Of the
patients who had successful placement of EC‑LAMS,
23 patients had a 15 mm wide × 10 mm long
EC‑LAMS placed, and two had a 10 mm × 10 mm
stent positioned. Of the 22 patients with WONs,
one had concomitant placement of a nasocystic
tube; the nasocystic tube was irrigated with normal
saline for 48–72 h after which it was removed.
There were no procedural related complications. The
median time for placement of the EC‑LAMS was
10.5 (range, 7–20) min.

Outcomes in patients with pancreatic fluid collections
after successful lumen‑apposing metal stent placement

The mean patient follow‑up period was 7.8 months
with a range of 3–9 months. The median number
of endoscopic sessions performed in patients with
PFCs to achieve PFC resolution was 2 (range 2–6).
Necrosectomy in was perfor med with an upper
endoscope through the EC‑LAMS in 71% of patients
with WON stent occlusion developed in one patient
who had a WON, and this patient was successfully
managed through endoscopic necrosectomy without
removal of the EC‑LAMS.
Long‑term success with endoscopic therapy of PFCs,
defined as complete resolution of the PFC was
achieved in 24/25 (94%) patients. Only one patient
with a WON did not achieve complete resolution. This
patient was referred for surgical necrosectomy.
There was a spontaneous extrusion of one EC‑LAMS
into the enteral lumen after resolution of the WONs.
All stents were successfully removed using a snare in all
of the remaining patients after PFC resolution. In all of
the cases, there were no significant AEs.
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DISCUSSION
EUS‑guided drainage of PFCs using novel
lumen‑apposing, fully covered, self‑expanding metal
stents has already been shown to have a high technical
and long‑term success rate in multiple studies. [13,14]
Conventionally, placement of LAMS has been
performed with the assistance of fluoroscopy by
inserting a guidewire through a needle into the cyst
cavity, dilating the cystoenterostomy fistula tract using
a wire‑guided balloon, and finally, advancing the LAMS
delivery catheter over the wire into the cyst cavity.
While this method has been shown to be effective,
the EC‑LAMS delivery system has the potential to
significantly simplify and streamline the process of
deploying LAMS by allowing for a single‑step procedure
without the need for fluoroscopic guidance. The
purpose of this study was to evaluate the clinical
outcomes and technical success rates for patients who
underwent a single‑step deployment of EC‑LAMS
without fluoroscopic guidance using the EC delivery
system.
Our study demonstrates that technical success and
clinical outcomes of single‑step deployment of
EC‑LAMS without the use of fluoroscopic guidance
is effective and safe. Technical success was achieved
in all 25 (100%) patients with no procedure‑related
complications, and resolution of PFCs was seen in
24 (96%) of patients, the one failure being in a patient
with WON who was referred for surgical necrosectomy.
Similar recent studies have separately investigated either
the feasibility of performing endoscopic drainage of
PFCs as a streamlined single‑step procedure using
the EC‑LAMS. Rinninella et al. evaluated 93 patients
who were retrospectively studied after undergoing
endoscopic treatment of PFCs using the EC‑LAMS
from 13 European tertiary care centers.[17] In their study,
access to the PFC was obtained directly as a single‑step
method using the EC‑LAMS in 69 (74.2%) patients.
For the remaining 24 patients, access to the PFC was
first obtained using a 19‑gauge needle, followed by
placement of a. 035‑inch guidewire over which the
EC‑LAMS was advanced. Results of their study revealed
a 98.9% technical success rate, and complete resolution
of the PFC in 93.5% of cases. A report by Seicean
et al. evaluated the feasibility of performing endoscopic
drainage of PFCs using plastic stents without fluoroscopic
guidance, though all of which were performed using a
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guidewire.[18] Seicean et al. found success rates comparable
with previously published studies using fluoroscopy, and
concluded that EUS‑guided drainage of PFCs is possible,
efficient, and safe without fluoroscopy in selected patients
who’s PFCs measure larger than 6 cm in diameter and
have a thin wall.

2.
3.
4.
5.
6.

The main limitation of our study is the relatively
small number of patients included. In addition, the
retrospective nature of the study includes inherent
limitations, such as variable follow‑up of patients,
quality of cross‑sectional imaging at different centers,
and variability in the technique of the endoscopist.
However, our population consisted of a heterogeneous
group of patients suffering from pancreatitis of
different etiologies who had considerable follow‑up
postprocedure.
CONCLUSION

7.

8.

9.

10.

11.

Our study builds on prior studies by demonstrating
that single‑step EUS‑guided drainage of PFCs without
fluoroscopic guidance using novel EC‑LAMS is a safe
and effective endoscopic technique for the drainage of
PFCs. Due to the ease of using EC‑LAMS without
fluoroscopic guidance, this method has the potential
to significantly simplify and streamline EUS‑guided
management of PFCs and help in its widespread
adoption as an alternative to surgery.
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